Different Oral Antithrombotic Therapy for the Treatment of Ventricular Thrombus: An Observational Study from 2010 to 2019

Figure 3

Bar chart comparing rates of thrombus resolution in patients with different antithrombotic therapy. A significant unadjusted difference in rates of resolution was observed among patients on NOACs, VKAs, and APT at 6 weeks’ ( = 0.0005), 12 weeks’ ( = 0.0032), and 6 months’ ( = 0.0844) follow-up, while there was no difference at 12 months’ ( = 0.3515) follow-up. VT: ventricular thrombus; NOACs: non-vitamin K antagonist oral anticoagulants; VKAs: vitamin K antagonists; APT: antiplatelet therapy.